Eyerising International

✨ Exciting News from Malaysia! ✨ We're thrilled to announce that our innovative Repeated Low-Level Red-Light (RLRL) Therapy for myopia management has reached even more children in Malaysia, thanks to our dedicated partner, Transmedic! 🌍 With proven efficacy in reducing myopia progression, the Eyerising Myopia Management device continues to make a positive impact on children’s vision worldwide. Together, we’re taking steps toward a myopia-free future. 👁️🌟 Learn more about our technology here: https://lnkd.in/gJEnNEq4 #MyopiaManagement #InnovationInVision #RedLightTherapy #EyerisingInternational #Transmedic #Malaysia

📢 Exciting News in Ophthalmology and RLRL! A new paper published in the American Journal of Ophthalmology sheds light on the impact of RLRL in high myopia among children. 🎉 🔍 Key Findings: 59% of the RLRL group experienced axial shortening greater than 0.05 mm after 12 months, while the control group saw no such changes. #eyerisinginternational #myopiamanagement #RLRL Read the full paper below: https://lnkd.in/gDCK7uBn

🌟 Exciting News 🌟 We recently conducted a series of insightful video interviews featuring global experts who shared their clinical experiences and observations with the Eyerising Myopia Management Device. Dr. Kate Gifford from Myopia Profile led these discussions, providing valuable insights into the future of myopia management. Catch the highlights of these engaging interviews and read the summaries to learn more about how these KOLs have incorporated RLRL in their practice. #myopiaprofile #myopiamanagement #eyerisinginternational https://lnkd.in/g_2xVBym

🌍 This World Sight Day, Eyerising International is excited to share an important initiative from the IPOSC Myopia Committee! We are proud to announce the launch of the IPOSC Global Myopia Study—an international, multicenter, multiethnic randomized controlled trial aimed at assessing the efficacy and safety of Repeated Low-level Red Light (RLRL) therapy in reducing myopia progression in children aged 6 to 12 years. To date, 20 centers from around the world have joined us in this crucial research. Together, we can make a significant impact on children's eye health globally this World Sight Day! #WorldSightDay #Myopia #RLRLTherapy #IPOSC #EyeHealth #Collaboration https://lnkd.in/gQa7eQ6c

🌟 We’re excited to share an insightful YouTube video between Diary of a CEO’s Stephen Bartlett and US optometrist Dr. Joseph Allen, who touched on the topic of red light therapy for myopia. 🌟 In this video, Joseph mentions the strong published efficacy of red light therapy in slowing myopia progression, and Stephen mentions the recent Nature review which discusses our unique 3-2-5 protocol. Joseph also recommends that red light therapy be used for myopia only under the prescription and supervision of eye care professionals, which we wholeheartedly agree with at Eyerising International, as that is why we are exclusively available via eye care professionals. Fantastic to hear red light therapy being talked about on such a global stage!  #eyerisinginternational #DOAC #StevenBartlett #myopiamanagement #RLRL https://lnkd.in/gEC7_-2m

📣 Eyerising Expert Video Interview Series Highlights is now on Myopia Profile 📣 Eyerising International recently undertook a series of video interviews where global experts spoke to Dr Kate Gifford of Myopia Profile about their clinical experiences, observations and work with the Eyerising Myopia Management Device Watch the video on the link below: https://lnkd.in/ggzZZZNM #myopiaprofile #eyerisinginternational #myopiamanagement

🚀 Milestone Alert! 🚀 We’re thrilled to announce a major achievement for Eyerising International: we’ve successfully reached 400 commercial patients using our Myopia Management Device outside of China! 🌍🎉 This milestone reflects our commitment to innovating and advancing myopia management on a global scale. A huge thank you to our dedicated team and partners for making this possible. Your support and hard work continue to drive us forward as we strive to make a positive impact on vision health worldwide. Here’s to many more milestones ahead! 🥂👓 #Milestone #Innovation #MyopiaManagement #EyerisingInternational

Eyerising Myopia Management Device Case study write up from New Zealand on NZ Optics!!! Full article below: https://lnkd.in/gVNCtiJ2

🎙️ Exciting News! Dr. Maria Gina Go from the Philippines recently shared her insights on myopia and the benefits of the EyeRising Myopia Management device on the show "Live Healthier Live Longer." 🌟👁️ Don't miss out on this enlightening discussion! Watch the full presentation here: #MyopiaManagement #EyeRising #HealthyVision #LiveHealthierLiveLonger #Optometry https://lnkd.in/gUcd6n7T

Article outlines the amazing results of RLRL in high myopia patients. “Repeated low-level red light demonstrates much stronger treatment efficacy among high myopia in children and adolescents aged six to 16 years, with 53.3% experiencing substantial axial shortening,” https://lnkd.in/gHzyvY6z